Citation only
via OpenAlex
Advanced Glycation End Products in Age-related Macular Degeneration
Archives of Ophthalmology · 1998 · ▲ 183 citations
Abstract
OBJECTIVE: To investigate the localization of N epsilon-(carboxymethyl)lysine (CML), a component and major immunologic epitope of advanced glycation end products, in aged eyes and choroidal neovascular membranes (CNVMs) surgically excised from eyes with age-related macular degeneration. METHODS: Immunohistochemistry for CML was performed using 8 snap-frozen, surgically excised CNVMs. Twelve eyes from patients aged 69 to 82 years and 2 donor eyes, 1 each from a 23-week-old fetus and 21-year-old patient, without age-related macular degeneration or diabetic retinopathy were also examined. To determine if retinal pigment epithelial cells in CNVMs accumulate advanced glycation end products, cytokeratin and CML were stained in paired serial sections. RESULTS: Soft, macular drusen and/or basal laminar and basal linear deposits were observed in 8 of 12 aged eyes. Each case showed CML accumulation, while overlying retinal pigment epithelial cells showed no accumulation in all 12 eyes. In CNVMs, however, retinal pigment epithelial cells showed CML accumulation in their cytoplasm. CONCLUSION: The additional accumulation of advanced glycation end products in soft, macular drusen and/or retinal pigment epithelial cells may play a role in the pathogenesis of CNVM formation in age-related macular degeneration. CLINICAL RELEVANCE: Recently, advanced glycation end products have been found to play a role both in aging changes and neovascularization. Localization of advanced glycation end products in the above-mentioned tissue may lead to a better understanding of the pathogenesis of age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1001/archopht.116.12.1629
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Ishibashi, T. (1998). Advanced Glycation End Products in Age-related Macular Degeneration. <em>Archives of Ophthalmology</em>. https://doi.org/10.1001/archopht.116.12.1629
Vancouver
Ishibashi T. Advanced Glycation End Products in Age-related Macular Degeneration. Archives of Ophthalmology. 1998. doi:10.1001/archopht.116.12.1629.
BibTeX
@article{tatsuro1998Advanc,
title = {Advanced Glycation End Products in Age-related Macular Degeneration},
author = {Tatsuro Ishibashi},
journal = {Archives of Ophthalmology},
year = {1998},
doi = {10.1001/archopht.116.12.1629},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
MedComm 2026
Open access · OA
Advanced Glycation End Products: From Pathogenesis to Treatment
American Journal of Ophthalmology 1992
Citation only
Surgical Excision of Subfoveal Neovascular Membranes in Age-related Macular Degeneration
American Journal of Ophthalmology 2000
Citation only
The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration
PubMed 2007
Preprint · OA
Oxidative damage in age-related macular degeneration.
Clinical Interventions in Aging 2008
Open access · CC-BY
Age-related macular degeneration and the aging eye
Neurobiology of Aging 2005
Citation only